Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study

Serum Anti-Müllerian Hormone Is Significantly Altered by Downregulation With Daily Gonadotropin-Releasing Hormone Agonist: A Prospective Cohort Study

Research Question: What is the effect of gonadotropin-releasing hormone (GnRH)-agonist treatment on serum anti-Müllerian hormone (AMH)?Design: This prospective cohort study conducted in a tertiary university hospital comprised patients (n = 52) who self-administered daily triptorelin (0.1 mg/0.1 mL)...

Full description

Bibliographic Details
Main Authors: Panagiotis Drakopoulos, Arne van de Vijver, Jose Parra, Ellen Anckaert, Johan Schiettecatte, Christophe Blockeel, Martin Hund, Wilma D. J. Verhagen-Kamerbeek, Ying He, Herman Tournaye, Nikolaos P. Polyzos
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-02-01
Series:Frontiers in Endocrinology
Subjects:
Elecsys® AMH
in vitro fertilization
ovarian reserve
ovarian response
GnRH agonist
Online Access:https://www.frontiersin.org/article/10.3389/fendo.2019.00115/full

Internet

https://www.frontiersin.org/article/10.3389/fendo.2019.00115/full

Similar Items